Citius Pharmaceuticals

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$0
$155
$155
Gross Profit
-41
-56
-54
-53
EBITDA
-8,726
-11,191
-9,984
-10,996
EBIT
-8,767
-11,247
-10,039
-11,050
Net Income
-8,789
-10,916
-9,768
-10,790
Net Change In Cash
0
0
155
155
Free Cash Flow
-5,406
-4,539
-4,725
-5,912
Cash
6,089
26
1,100
3,251
Basic Shares
11,006
11,590
11,590
11,590

Annual Financials

Values in thousands 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Revenue
$0
$0
$0
$0
Gross Profit
-209
-194
-179
-164
EBITDA
-38,640
-31,772
-32,884
-22,878
EBIT
-38,849
-31,966
-33,064
-23,043
Net Income
-39,138
-32,542
-33,640
-23,125
Net Change In Cash
0
0
0
0
Cost of Revenue
-28,361
56,213
Free Cash Flow
-28,201
-29,060
-28,361
-64,257
Cash
3,251
26,480
41,711
70,072
Basic Shares
11,590
10,086
9,738
7,239

Earnings Calls

Quarter EPS
2025-06-30
-$0.80
2025-03-31
-$1.27
2024-12-31
-$1.30
2024-09-30
-$1.58